Question 1

Has Ulhas Nadgir received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $721,381 in general payments to Ulhas Nadgir across 748 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Ulhas Nadgir did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Ulhas Nadgir come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Dexcom, Inc.	33	$520,668
Ascendis Pharma Endocrinology Inc	45	$96,471
Janssen Research & Development, LLC	11	$79,161
Astrazeneca UK Limited	5	$13,806
AbbVie	178	$2,124
Novo Nordisk	94	$1,069
Tandem Diabetes Care, Inc.	40	$1,050
Abbott	38	$828
Mannkind Corporation	39	$752
AstraZeneca	22	$633
Lilly USA, LLC	39	$611
Insulet Corporation	26	$505
Medtronic(2 entities)	19	$461
Pfizer	15	$297
BETA Bionics, Inc.	6	$281
Azurity Pharmaceuticals, Inc.	15	$258
Sanofi-aventis U.S. LLC	15	$248
Biomarin Pharmaceutical Inc.	17	$243
Companion Medical, Inc.	12	$235
Zealand Pharma US, Inc.	13	$224
Tolmar Pharmaceuticals, Inc.	9	$194
Tolmar, Inc.	8	$186
Neurocrine Biosciences, Inc.	2	$147
Ultragenyx Pharmaceutical Inc.	6	$136
Xeris Pharmaceuticals, Inc.	8	$136
BD	4	$99
Kyowa Kirin, Inc.	4	$97
Soleno Therapeutics, Inc.	3	$73
Lifescan, Inc.	4	$65
Ipsen Biopharmaceuticals, Inc	2	$48
Ferring Pharmaceuticals Inc.	3	$44
Arbor Pharmaceuticals, Inc.	2	$34
Krystal Biotech Inc	1	$31
IBSA Pharma Inc.	2	$28
Endo Pharmaceuticals Inc.	2	$27
Embecta Corp.	1	$21
Amphastar Pharmaceuticals, Inc.	1	$20
Endo USA, Inc.	1	$20
Ascensia Diabetes Care US Inc.	1	$19
Nevro Corp.	1	$17
Cequr Corporation	1	$13

Ulhas Nadgir

Payments from drug & device makers

Who reported the general payments

How this compares

Other pediatric endocrinology in Sacramento